Health Care & Life Sciences » Pharmaceuticals | M Pharmaceutical Inc.

M Pharmaceutical Inc. | Balance Sheet

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
50.00
281.30
1.50
715.30
16.10
Total Accounts Receivable
22.40
5.20
2.90
22.80
21.90
Inventories
-
-
-
-
113.80
Other Current Assets
58.90
35.70
8.70
53.60
33.10
Total Current Assets
131.20
322.10
13.10
791.70
185.00
Net Property, Plant & Equipment
6,063.90
-
-
8.30
5.80
Long-Term Note Receivable
23.80
-
-
-
-
Intangible Assets
-
-
569.80
2,010.70
4,367.00
Other Assets
-
180.00
-
-
-
Total Assets
6,219.00
502.10
582.90
2,810.70
4,557.70
ST Debt & Current Portion LT Debt
-
-
218.20
448.10
257.70
Accounts Payable
703.50
40.90
-
-
871.50
Other Current Liabilities
-
598.00
1,469.10
2,144.20
3,553.90
Total Current Liabilities
703.50
638.80
1,687.40
2,592.30
4,683.10
Long-Term Debt
275.30
66.90
-
-
-
Total Liabilities
978.90
705.70
1,687.40
2,592.30
4,683.10
Common Equity (Total)
5,240.10
203.60
1,104.50
218.40
125.40
Total Shareholders' Equity
5,240.10
203.60
1,104.50
218.40
125.40
Total Equity
5,240.10
203.60
1,104.50
218.40
125.40
Liabilities & Shareholders' Equity
6,219.00
502.10
582.90
2,810.70
4,557.70

About M Pharmaceutical

View Profile
Address
187 Pavilion Parkway
Newport Québec 41071
Canada
Employees -
Website http://www.callitas.com
Updated 07/08/2019
Callitas Health, Inc. is a clinical stage company. It engages in the development of technologies for obesity, weight management, and female health and wellness. The company focuses on developing technologies for weight management, female sexual health and wellness, cannabis delivery technologies and other proprietary drugs.